Table 1. Prevalent statin use at study entry. Figures are frequencies (column percent).

				Year of entry to study				P value (test for trend)
		2001-2005		2006-2010		2011-2015
		Freq.	%	Freq.	%	Freq.	%
Total		8,091 / 81,353	9.9	23,293 / 66,817	34.9	31,747 / 64,396	49.3	<0.001
Gender	Male	3,013 / 24,251	12.4	8,780 / 22,004	39.9	12,492 / 22,746	54.9	<0.001
	Female	5,078 / 57,102	8.9	14,513 / 44,813	32.4	19,255 / 41,650	46.2	<0.001
Age Group	80-84	4,367 / 23,673	18.5	10,764 / 23,132	46.5	13,486 / 23,060	58.5	<0.001
	85-89	2,455 / 22,130	11.1	7,541 / 19,793	38.1	10,103 / 18,981	53.2	<0.001
	90-94	1,060 / 20,412	5.2	3,863 / 15,327	25.2	6,233 / 14,724	42.3	<0.001
	95-99	196 / 12,823	1.5	1,096 / 7,989	13.7	1,838 / 6,905	26.6	<0.001
	100+	13 / 2,315	0.6	29 / 576	5.0	87 / 726	12.0	<0.001
Frailty	Fit	1,956 / 36,500	5.4	3,159 / 17,190	18.4	3,224 / 12,394	26.0	<0.001
	Mild	3,458 / 28,373	12.2	8,855 / 25,744	34.4	10,587 / 23,052	45.9	<0.001
	Moderate	1,993 / 12,691	15.7	7,478 / 16,811	44.4	10,954 / 18,814	58.2	<0.001
	Severe	684 / 3,789	18.0	3,801 / 7,072	53.7	6,982 / 10,136	68.9	<0.001
Prevention Type	Primary	2,251 / 57,155	3.9	7,815 / 43,397	18.0	12,146 / 39,892	30.4	<0.001
	Secondary	5,840 / 24,198	24.1	15,478 / 23,420	66.1	19,601 / 24,504	80.0	<0.001